135 related articles for article (PubMed ID: 35060532)
1. A case report of a patient with inoperable primary diffuse leptomeningeal melanomatosis treated with whole-brain radiotherapy and pembrolizumab.
Palacka P; Slopovsky J; Makovnik M; Kajo K; Obertova J; Mego M
Medicine (Baltimore); 2022 Jan; 101(3):e28613. PubMed ID: 35060532
[TBL] [Abstract][Full Text] [Related]
2. Primary leptomeningeal melanomatosis successfully treated with PD-1 inhibitor pembrolizumab: A case report.
Misir Krpan A; Rakusic Z; Herceg D
Medicine (Baltimore); 2020 Dec; 99(50):e22928. PubMed ID: 33327228
[TBL] [Abstract][Full Text] [Related]
3. Pediatric primary diffuse leptomeningeal melanomatosis: Case report and review of the literature.
Xu X; Zheng Y; Li J; Wang F; Li F
Medicine (Baltimore); 2020 Feb; 99(8):e19178. PubMed ID: 32080099
[TBL] [Abstract][Full Text] [Related]
4. Primary Diffuse Leptomeningeal Melanomatosis: Case Report and Review of the Literature.
Eichberg DG; Achua JK; Locatelli E; Shah AH; Komotar RJ; Ghods AJ
World Neurosurg; 2019 Feb; 122():648-655. PubMed ID: 30496931
[TBL] [Abstract][Full Text] [Related]
5. Primary Diffuse Leptomeningeal Melanomatosis of Spine: 18F-FDG PET Findings.
Ayan A; Akbulut A; Deveci G; Koca G
Clin Nucl Med; 2019 Feb; 44(2):137-139. PubMed ID: 30516687
[TBL] [Abstract][Full Text] [Related]
6. Clinical and radiological response of leptomeningeal melanoma after whole brain radiotherapy and ipilimumab.
Bot I; Blank CU; Brandsma D
J Neurol; 2012 Sep; 259(9):1976-8. PubMed ID: 22527228
[No Abstract] [Full Text] [Related]
7. Primary central nervous system malignant melanoma with leptomeningeal melanomatosis: a case report and review of the literature.
Fujimori K; Sakai K; Higashiyama F; Oya F; Maejima T; Miyake T
Neurosurg Rev; 2018 Jan; 41(1):333-339. PubMed ID: 28986666
[TBL] [Abstract][Full Text] [Related]
8. NRAS
Girolami I; Cima L; Ghimenton C; Zannoni M; Mombello A; Riva G; Cirielli V; Corradi G; Vogrig A; Di Stefano G; Novelli L; Gessi M; Eccher A
Brain Tumor Pathol; 2018 Oct; 35(4):217-223. PubMed ID: 30145692
[TBL] [Abstract][Full Text] [Related]
9. Primary diffuse meningeal melanomatosis.
Zadro I; Brinar VV; Barun B; Ozretić D; Pazanin L; Grahovac G; Habek M
Neurologist; 2010 Mar; 16(2):117-9. PubMed ID: 20220448
[TBL] [Abstract][Full Text] [Related]
10. Primary Diffuse Leptomeningeal Melanomatosis in an Indian Child With Review of Literature.
Kumar A; Gunasekaran PK; Aggarwal D; Janu V; Manjunathan S; Laxmi V; Tiwari S; Saini L
Pediatr Neurol; 2024 Mar; 152():23-29. PubMed ID: 38176225
[TBL] [Abstract][Full Text] [Related]
11. Two cases of primary leptomeningeal melanomatosis mimicking subacute meningitis.
Aslan S; Gocmen R; Acar NP; Khasiyev F; Gumeler E; Soylemezoglu F; Tuncer A; Arsava EM; Topçuoglu MA; Unal Cevik I
Neuroradiol J; 2018 Feb; 31(1):42-46. PubMed ID: 28627959
[TBL] [Abstract][Full Text] [Related]
12. Primary Diffuse Leptomeningeal Melanomatosis in a Child with Extracranial Metastasis: Case Report.
Shahab SW; Patil P; Fangusaro JR; Patteson B; Goldman-Yassen A; Eaton BR; Boydston W; Schniederjan M; Aguilera D
Curr Oncol; 2024 Jan; 31(1):579-587. PubMed ID: 38275834
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the Abscopal Effect With Anti-PD1 Therapy in Patients With Metastatic Solid Tumors.
Ribeiro Gomes J; Schmerling RA; Haddad CK; Racy DJ; Ferrigno R; Gil E; Zanuncio P; Buzaid AC
J Immunother; 2016; 39(9):367-372. PubMed ID: 27741091
[TBL] [Abstract][Full Text] [Related]
14. Brain Atrophy Associated with Primary Diffuse Meningeal Melanomatosis.
Ma Y; Xing X; Li Y; Ao R; He M; Lan X; Zhao Y; Zhang J; Yu S
World Neurosurg; 2020 Apr; 136():311-314. PubMed ID: 32004738
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic challenges of primary diffuse leptomeningeal melanomatosis in early adolescence: A case report.
Yamauhci S; Fukuyama T; Inaba Y; Nakajima H; Hattori Y; Miyairi Y; Ogiso Y
Brain Dev; 2022 Jun; 44(6):421-425. PubMed ID: 35260265
[TBL] [Abstract][Full Text] [Related]
16. Primary pineal melanoma with leptomeningeal spreading: case report and review of the literature.
Martin-Blondel G; Rousseau A; Boch AL; Cacoub P; Sène D
Clin Neuropathol; 2009; 28(5):387-94. PubMed ID: 19788056
[TBL] [Abstract][Full Text] [Related]
17. Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition.
Blake Z; Marks DK; Gartrell RD; Hart T; Horton P; Cheng SK; Taback B; Horst BA; Saenger YM
J Immunother Cancer; 2018 Apr; 6(1):25. PubMed ID: 29622046
[TBL] [Abstract][Full Text] [Related]
18. Pearls & Oy-sters: Primary Diffuse Leptomeningeal Melanocytosis: A Diagnostic Conundrum.
Selvarajan JMP; Epari S; Sahu A; Dasgupta A; Chatterjee A; Gupta T
Neurology; 2023 Aug; 101(5):e576-e580. PubMed ID: 36878703
[TBL] [Abstract][Full Text] [Related]
19. Primary melanocytic neoplasms of the central nervous system.
Liubinas SV; Maartens N; Drummond KJ
J Clin Neurosci; 2010 Oct; 17(10):1227-32. PubMed ID: 20558070
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint inhibitors of CTLA4 and PD-1 for malignant melanoma arising in ovarian cystic teratoma: A case report.
Yano M; Asami Y; Nishikawa T; Yoshida S; Kamada K; Katoh T; Teramoto Y; Nakamura Y; Yasuda M
Medicine (Baltimore); 2018 Oct; 97(43):e12937. PubMed ID: 30412106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
